🇺🇸 FDA
Pipeline program

Hypnotic Medication Open-Label Taper

HS3239

Phase 3 other active

Quick answer

Hypnotic Medication Open-Label Taper for Hypnotic Dependence Among Those With Insomnia is a Phase 3 program (other) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Hypnotic Dependence Among Those With Insomnia
Phase
Phase 3
Modality
other
Status
active

Clinical trials